Fund Holdings — Artia Global Partners LP

Total Portfolio Value:
$622.42M
Total Bought:
$232.38M
Total Sold:
$185.86M
Net Transaction:
+$46.52M
Notable People:
Onusa Nmn Chantanapongwanij, Artia Global Partners Gp Llc
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)732,212682,212-50,000$105.45M$118.73M19.08%+$13.29M
ABIVAX Société AnonymeADS(ABVX)225,453600,747+375,294$19.14M$81.01M13.02%+$61.87M
argenx SEADR(ARGX)78,31164,699-13,612$57.76M$54.41M8.74%-$3.35M
Eli Lilly and Company(LLY)28,70050,500+21,800$21.90M$54.27M8.72%+$32.37M
Viking Therapeutics, Inc.(VKTX)146,179719,365+573,186$3.84M$25.31M4.07%+$21.47M
Trevi Therapeutics, Inc.(TRVI)1,999,7022,013,602+13,900$18.30M$25.21M4.05%+$6.91M
Soleno Therapeutics Inc672,176533,698-138,478$45.44M$24.71M3.97%-$20.73M
ProShares Ultra SilverULTRA GOLD(AGQ)537,372442,119-95,253$24.75M$24.55M3.94%-$204.9K
uniQure N.V.SHS(QURE)658,8391,023,539+364,700$38.46M$24.49M3.94%-$13.96M
Newamsterdam Pharma Company
ORDINARY SHARES
194,838503,936+309,098$5.54M$17.68M2.84%+$12.14M
AstraZeneca PLCADR(AZN)190,752190,7520$14.63M$17.54M2.82%+$2.90M
Cidara Therapeutics Inc070,824+70,824$0$15.64M2.51%+$15.64M
EyePoint, Inc.(EYPT)628,367767,098+138,731$8.95M$14.01M2.25%+$5.07M
Ionis Pharmaceuticals, Inc.(IONS)60,176144,376+84,200$3.94M$11.42M1.84%+$7.48M
Dianthus Therapeutics, Inc.(DNTH)108,723205,090+96,367$4.28M$8.45M1.36%+$4.17M
Revolution Medicines, Inc.(RVMD)104,190104,1900$4.87M$8.30M1.33%+$3.43M
Quest Diagnostics Incorporated(DGX)81,71740,817-40,900$15.57M$7.08M1.14%-$8.49M
Alnylam Pharmaceuticals, Inc.(ALNY)34,57017,400-17,170$15.76M$6.92M1.11%-$8.84M
Ventyx Biosciences Inc0695,982+695,982$0$6.28M1.01%+$6.28M
Palvella Therapeutics, Inc.(PVLA)059,200+59,200$0$6.20M1.00%+$6.20M
Mineralys Therapeutics, Inc.(MLYS)56,600137,800+81,200$2.15M$5.00M0.80%+$2.85M
Sionna Therapeutics, Inc.(SION)0119,741+119,741$0$4.93M0.79%+$4.93M
Palisade Bio, Inc.(PALI)01,992,367+1,992,367$0$4.68M0.75%+$4.68M
Avidity Biosciences Inc110,10060,100-50,000$4.80M$4.34M0.70%-$462.0K
Scholar Rock Holding Corporation(SRRK)96,28596,2850$3.59M$4.24M0.68%+$655.7K
Rapport Therapeutics, Inc.(RAPP)64,608138,508+73,900$1.92M$4.20M0.68%+$2.28M
ProKidney Corp.CL A(PROK)01,838,411+1,838,411$0$4.12M0.66%+$4.12M
Ascendis Pharma A/SADR(ASND)12,24017,740+5,500$2.43M$3.78M0.61%+$1.35M
AbbVie Inc.(ABBV)14,50014,5000$3.36M$3.31M0.53%-$44.2K
Belite Bio, IncADS(BLTE)017,989+17,989$0$2.88M0.46%+$2.88M
Roivant Sciences Ltd.SHS(ROIV)0129,800+129,800$0$2.82M0.45%+$2.82M
Travere Therapeutics, Inc.(TVTX)30,90070,700+39,800$738.5K$2.70M0.43%+$1.96M
Bright Minds Biosciences Inc.(DRUG)033,407+33,407$0$2.61M0.42%+$2.61M
United Therapeutics Corporation(UTHR)5,0005,0000$2.10M$2.44M0.39%+$340.2K
Protagonist Therapeutics Inc22,95122,9510$1.52M$2.00M0.32%+$479.9K
Upstream Bio, Inc.(UPB)068,653+68,653$0$1.86M0.30%+$1.86M
Xenon Pharmaceuticals Inc.(XENE)40,00040,0000$1.61M$1.79M0.29%+$186.8K
Ocular Therapeutix, Inc.(OCUL)141,061141,0610$1.65M$1.71M0.28%+$63.5K
BridgeBio Pharma, Inc.(BBIO)20,40020,4000$1.06M$1.56M0.25%+$500.8K
BrightSpring Health Services, Inc.(BTSG)41,60041,6000$1.23M$1.56M0.25%+$328.2K
PepGen Inc.(PEPG)0205,324+205,324$0$1.34M0.21%+$1.34M
Celcuity Inc.(CELC)012,900+12,900$0$1.29M0.21%+$1.29M
Kiniksa Pharmaceuticals International, plcCL A(KNSA)29,20029,2000$1.13M$1.20M0.19%+$70.7K
Nuvalent Inc08,100+8,100$0$814.8K0.13%+$814.8K
Avalo Therapeutics, Inc.(AVTX)041,570+41,570$0$754.9K0.12%+$754.9K
Praxis Precision Medicines, Inc.(PRAX)02,500+2,500$0$736.9K0.12%+$736.9K
Alto Neuroscience, Inc.(ANRO)029,192+29,192$0$519.6K0.08%+$519.6K
Tenax Therapeutics, Inc.(TENX)042,080+42,080$0$513.0K0.08%+$513.0K
Kodiak Sciences Inc.(KOD)017,019+17,019$0$475.9K0.08%+$475.9K
Lyra Therapeutics Inc08,756+8,756$0$27.0K0.00%+$27.0K
Alector Inc71,0290-71,029$210.2K$0—-$210.2K
Atyr Pharma Inc372,2760-372,276$268.6K$0—-$268.6K
Biohaven Ltd.(BHVN)80,0000-80,000$1.20M$0—-$1.20M
Boston Scientific Corporation(BSX)183,2000-183,200$17.89M$0—-$17.89M
Centessa Pharmaceuticals PlcADS133,2910-133,291$3.23M$0—-$3.23M
Iren Limited
ORDINARY SHARES
33,2000-33,200$1.56M$0—-$1.56M
Kalvista Pharmaceuticals Inc41,5550-41,555$506.1K$0—-$506.1K
Mereo BioPharma Group plcADS(MREO)475,3610-475,361$979.2K$0—-$979.2K
Moderna, Inc.(MRNA)23,8000-23,800$614.8K$0—-$614.8K
Merus N V296,7500-296,750$27.94M$0—-$27.94M
Nektar Therapeutics(NKTR)57,9990-57,999$3.30M$0—-$3.30M
Ultragenyx Pharmaceutical Inc.(RARE)64,5020-64,502$1.94M$0—-$1.94M
Regeneron Pharmaceuticals, Inc.(REGN)10,6710-10,671$6.00M$0—-$6.00M
Sarepta Therapeutics, Inc.(SRPT)44,9000-44,900$865.2K$0—-$865.2K
TG Therapeutics, Inc.(TGTX)54,5150-54,515$1.97M$0—-$1.97M
Verona Pharma PlcADS379,0040-379,004$40.44M$0—-$40.44M
Vertex Pharmaceuticals Incorporated(VRTX)55,1000-55,100$21.58M$0—-$21.58M
Page 1 of 1
Artia Global Partners LP — 13F Holdings — Q4 2025 | TickerTrail